ADMS 30/07 1/2 RC 03/20 4 February 2020 Subject : Report on the Company’s operating results for the year 2019 Attention : President of the Stock Exchange of Thailand Jasmine International Public

No. KK ELCID 2563/001 October 6, 2020 Subject: Management Discussion and Analysis for the second quarter ended June 30, 2020 To: President The Stock Exchange of Thailand K&K Superstore Southern

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as

According to the referral from the Stock Exchange of Thailand (SET), persons were found to have taken action liable to be an offense related to the sales of SQ shares by using inside information on

Mr. Alex as PP investor; benefits CIG will gain from offering PP shares, feasibility of plans for use of proceeds from PP offering, clarity regarding project implementation including sufficiency of

currently in the process of drafting regulations, which are expected to be enforced within this year, that would permit the social enterprises, who are non-profit unlike ordinary businesses, to offer stock

investors, which can lead to business expansion, employment, and more competitive edge of local businesses. This translates into the overall economic benefits of the country at large thanks to a close

and the persons whom IFEC identified as director via the Stock Exchange of Thailand (SET) to solve the company's problems urgently and to disclose their individual clarifications to the public within

such information to another person (tippee) who also must not seek unfair benefits or forward the information to any subsequent person. By law, it is initially presumed that an insider (e.g., director or